BioRem Inc.
BIRMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11,253 | $9,431 | $4,730 | $9,315 |
| % Growth | 19.3% | 99.4% | -49.2% | – |
| Cost of Goods Sold | $8,087 | $6,881 | $3,621 | $7,718 |
| Gross Profit | $3,166 | $2,550 | $1,110 | $1,597 |
| % Margin | 28.1% | 27% | 23.5% | 17.1% |
| R&D Expenses | $35 | $16 | $14 | $7 |
| G&A Expenses | $474 | $949 | $457 | $395 |
| SG&A Expenses | $1,521 | $1,476 | $1,023 | $1,295 |
| Sales & Mktg Exp. | $1,047 | $528 | $565 | $901 |
| Other Operating Expenses | -$429 | $4 | -$21 | $8 |
| Operating Expenses | $1,128 | $1,496 | $1,016 | $1,311 |
| Operating Income | $1,613 | $1,054 | $94 | $287 |
| % Margin | 14.3% | 11.2% | 2% | 3.1% |
| Other Income/Exp. Net | -$38 | -$41 | -$44 | -$47 |
| Pre-Tax Income | $1,575 | $1,013 | $51 | $240 |
| Tax Expense | $300 | $269 | $13 | $69 |
| Net Income | $831 | $745 | $37 | $171 |
| % Margin | 7.4% | 7.9% | 0.8% | 1.8% |
| EPS | 0.052 | 0.047 | 0.002 | 0.011 |
| % Growth | 11.6% | 2,225% | -81.7% | – |
| EPS Diluted | 0.045 | 0.04 | 0.002 | -0.023 |
| Weighted Avg Shares Out | 16,006 | 16,030 | 18,582 | 15,765 |
| Weighted Avg Shares Out Dil | 18,630 | 18,606 | 18,582 | 15,659 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $28 | $41 | $44 | $47 |
| Depreciation & Amortization | $133 | $109 | $134 | $140 |
| EBITDA | $1,746 | $1,163 | $229 | $427 |
| % Margin | 15.5% | 12.3% | 4.8% | 4.6% |